Cheeloo College of Medicine, Shandong University, No. 44 Wenhua West Road, Lixia District, Jinan, 250012, Shandong Province, China.
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, No. 107, Wenhua West Road, Jinan, 250012, Shandong Province, China.
BMC Bioinformatics. 2023 Apr 13;24(1):146. doi: 10.1186/s12859-023-05239-7.
The aim was to develop a personalized survival prediction deep learning model for cervical adenocarcinoma patients and process personalized survival prediction.
A total of 2501 cervical adenocarcinoma patients from the surveillance, epidemiology and end results database and 220 patients from Qilu hospital were enrolled in this study. We created our deep learning (DL) model to manipulate the data and evaluated its performance against four other competitive models. We tried to demonstrate a new grouping system oriented by survival outcomes and process personalized survival prediction by using our DL model.
The DL model reached 0.878 c-index and 0.09 Brier score in the test set, which was better than the other four models. In the external test set, our model achieved a 0.80 c-index and 0.13 Brier score. Thus, we developed prognosis-oriented risk grouping for patients according to risk scores computed by our DL model. Notable differences among groupings were observed. In addition, a personalized survival prediction system based on our risk-scoring grouping was developed.
We developed a deep neural network model for cervical adenocarcinoma patients. The performance of this model proved to be superior to other models. The results of external validation supported the possibility that the model can be used in clinical work. Finally, our survival grouping and personalized prediction system provided more accurate prognostic information for patients than traditional FIGO stages.
本研究旨在为宫颈腺癌患者开发一种个性化生存预测深度学习模型,并进行个性化生存预测。
本研究共纳入来自监测、流行病学和最终结果数据库的 2501 例宫颈腺癌患者和齐鲁医院的 220 例患者。我们创建了深度学习(DL)模型来处理数据,并将其性能与其他四个竞争模型进行了评估。我们试图通过使用我们的 DL 模型展示一种新的基于生存结果的分组系统,并进行个性化生存预测。
在测试集中,DL 模型的 c 指数达到 0.878,Brier 得分达到 0.09,优于其他四个模型。在外部测试集中,我们的模型获得了 0.80 的 c 指数和 0.13 的 Brier 得分。因此,我们根据我们的 DL 模型计算的风险评分,为患者开发了预后导向的风险分组。在分组中观察到明显的差异。此外,还开发了基于我们风险评分分组的个性化生存预测系统。
我们开发了一种用于宫颈腺癌患者的深度神经网络模型。该模型的性能被证明优于其他模型。外部验证的结果支持该模型可用于临床工作的可能性。最后,我们的生存分组和个性化预测系统为患者提供了比传统 FIGO 分期更准确的预后信息。